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Background. Glomerular and tubulointerstitial accumulations
of macrophages and T cells are a prominent feature of immune
inflammatory glomerulonephritis. The C-C family of chemokines
are major mononuclear-cell chemoattractants and may be central
to the recruitment of these cells.
Methods. Using in situ hybridization (ISH) we analyzed the
expression of mRNA for the C-C chemokines monocyte chemoat-
tractant protein-1 (MCP-1), macrophage inflammatory pro-
tein-1a and b (MIP-1a, MIP-1b) and RANTES in renal biopsy
material from twenty patients with glomerulonephritis.
Results. In overt inflammatory glomerulonephritides, chemo-
kine transcripts were differentially expressed by glomerular and
tubulointerstitial leukocyte infiltrates, glomerular parietal and
proximal tubular epithelial cells and endothelial cells. There was
little expression in minimal change nephropathy and normal
tissue. Expression of individual chemokines correlated with intra-
renal T cell and macrophage infiltrates. Combined immunohisto-
chemistry and ISH demonstrated that 56.9% of cells expressing
MCP-1 mRNA were CD681ve (monocytes/macrophages) and
53% of infiltrating CD68 1ve cells were MCP-1 mRNA positive.
Conclusions. These studies indicate that the in situ production
of C-C chemokines by resident and infiltrating cells may play a
crucial role in regulating macrophage and T-cell recruitment in
glomerulonephritis.
Immune inflammatory human glomerulonephritis is as-
sociated with the accumulation of heavy macrophage and T
cell infiltrates at glomerular, periglomerular and tubuloin-
terstitial sites [1, 2]. A substantial proportion of these cells
are activated and localized to areas of injury [3–5] where
they may have a central role in mediating tissue damage.
The trafficking of circulating leukocytes to inflammatory
sites is directed by a multi-step cascade of molecular
interactions co-ordinated by locally expressed chemoattrac-
tant and adhesion molecules [6]. The 8 to 11 kD chemo-
kines are small chemoattractant cytokines that are pro-
duced by a wide variety of stimulated cell types including
leukocytes and resident renal cells [7]. They have a central
role at two points in this process by (i) activating leukocyte
integrin molecules to facilitate firm endothelial adhesion
[8] and (ii) providing a chemotactic gradient for trans- and
sub-endothelial leukocyte migration [9, 10]. The chemokine
superfamily is divided into four subgroups, based on the
arrangement of the first two cysteine residues [11, 12].
Members of individual subgroups direct the chemotaxis
and activation of specific leukocyte subsets, and their
differential expression at sites of inflammation dictate
tissue infiltrating leukocyte profiles [7, 11]. The C-C che-
mokines predominantly direct the recruitment of macro-
phages [13] and T cells [14–16]. On stimulation by proin-
flammatory mediators, cultured human mesangial and
proximal tubular epithelial cells produce the C-C chemo-
kine monocyte chemoattractant protein-1 (MCP-1) [17,
18]. Studies of human renal inflammation have demon-
strated the expression of MCP-1 in inflammatory glomer-
ulonephritis [19, 20] and MCP-1 and RANTES in acute
transplant rejection [21, 22]. Recently Gesualdo and col-
leagues extended these observations to demonstrate the
expression of MCP-1 mRNA and protein in cryoglobuli-
naemic glomerulonephritis and colocalized macrophage
infiltration to MCP-1 expression [23]. Animal models of
acute glomerulonephritis, however, demonstrate the abro-
gation of only a minority of infiltrating macrophages by
anti-MCP-1 antibodies [24, 25], suggesting the presence of
other macrophage directed chemokines. MCP-1 is also a
potent T cell chemoattractant [14] but its role in T cell
recruitment in renal inflammation has not been studied. To
date over 20 human C-C chemokines have been identified,
many of which are candidate molecules for macrophage
and T cell recruitment in human glomerulonephritis. Stud-
ies of inflammation in other organ systems support this
potential role [26, 27].
We have used in situ hybridization to study the expres-
sion and distribution of mRNA for the C-C chemokines
MCP-1, macrophage inflammatory protein-1a (MIP-1a),
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MIP-1b and RANTES in renal biopsy material from pa-
tients with immune inflammatory GN. Here we demon-
strate the differential expression of these molecules by
resident and infiltrating cells and their colocalization to,
and correlation with, infiltrating macrophages and T cells.
METHODS
Tissue collection and preparation
Following local ethical committee permission and in-
formed consent, renal biopsies were obtained from 20
patients with a clinical diagnosis of immune inflammatory
glomerulonephritis (Table 1). Patients with Wegener’s
granulomatosis and microscopic polyangiitis were diag-
nosed according to the names and definitions of the Chapel
Hill Consensus conference [28]. Control tissue comprised
biopsies from patients with minimal change nephropathy
(N 5 3) and cortical fragments from the unaffected pole of
kidneys removed for renal cell carcinoma (N 5 5). Each
biopsy was immediately embedded in Brights cryo-m-bed
medium (BDH, Dorset, UK), snap frozen in liquid nitrogen
and stored at 270°C until sectioning. For in situ hybridiza-
tion (ISH) and combined immunohistochemistry/ISH stud-
ies 7 mm cryostat sections were collected onto Superfrost
Plus slides (BDH) and immediately fixed in freshly pre-
pared 4% paraformaldehyde (PFH) in phosphate buffered
saline (PBS, pH 7.4) for two hours at 4°C, washed briefly
(32) in diethyl pyrocarbonate (DEPC) treated water,
vacuum desiccated and stored at 270°C until use. Cryostat
sections for immunocytochemistry studies were air dried,
fixed in acetone for 10 minutes, and stored at 220°C until
use. Where serial PFH and acetone fixed sections were
available colocalization of mRNA to CD68 1ve (macro-
phages) and CD3 1ve (T cells) cells was studied. Colocal-
ization of MCP-1 with CD68 1ve cells was further analyzed
by combined immunohistochemistry/ISH on single sections
from three biopsies with ANCA-associated glomerulone-
phritis and one biopsy with anti-GBM disease. Unless
otherwise indicated all reagents were obtained from Sigma
(Dorset, UK).
Riboprobe synthesis
Riboprobes were synthesized from MCP-1, MIP-1a,
MIP-1b and RANTES specific complementary DNA frag-
ments of between 300 to 350 bp length ligated into SalI/
EcoRI (for MCP-1) or EcoRI/BamHI restriction sites
within the polycloning region of the Bluescript II SK
plasmid vector. Sense and antisense probes were synthe-
sized using T7 and T3 DNA-dependent RNA polymerase
promoters (Promega, WI, USA) in a transcription reaction
incorporating 50 mCi of 35S UTP (Dupont, Stevenage, UK).
Probes were labeled to a specific activity of 1 to 2 3 108
dpm/mg, purified on RNase free sephadex G50 columns
(Amersham, UK) and characterized by polyacrylamide/
urea gel electrophoresis alongside transcription generated
labeled standards (data not shown). Labeled probe (2 3
107 cpm) was diluted to a volume of 208 ml in 50 ml tRNA
(10 mg/ml), 50 ml denatured herring sperm DNA, 10 ml 1 M
dithiothreitol (DTT) and DEPC treated water, heated at
Table 1. Clinicala, laboratorya and biopsy features of patient group
Patient Sex/age Immunology Diagnosis Cr mmol/liter Treatment
% Glomeruli with
active lesions
1b M/16 pANCA MPA 80 Aza/Pred 11.8
2b M/30 Anti-GBM Anti-GBM 1057 Pred 93.8
3 M/30 cANCA WG 250 Cyclo/pred 33
4 F/33 ANA SLE 123 Pred 14.2
5b F/38 cANCA WG 529 Pred 40
6b M/38 -ve HSN 320 nil 11.8
7 M/39 NA MPA 114 nil 19.2
8b F/41 pANCA MPA 127 nil 50
9 M/58 pANCA MPA 945 nil 35.7
10 F/58 pANCA MPA 919 nil 89.5
11 M/60 ANA/Anti-ssDNA SLE 96 Pred 55
12b M/63 cANCA MPA 230 Cyclo/MP 34.8
13 M/65 -ve HSN 147 nil 25
14b F/66 cANCA WG 460 MP 66.6
15b F/68 cANCA WG/ 436 nil 38.5
16b F/68 Anti-GBM Anti-GBM 754 nil 92.9
17 M/69 cANCA WG 204 Cyclo/Pred 24
18b F/70 pANCA MPA 176 nil 50
19 M/71 -ve HSN 148 nil 24.2
20 M/71 cANCA RLV 80 Cyclo/pred 4.8
Abbreviations are: Cr, creatinine; F, female; M, male; ANCA, anti neutrophil cytoplasmic autoantibody; p, perinuclear; c, cytoplasmic; ANA,
anti-nuclear antibodies; Anti-GBM, anti-glomerular basement membrane antibodies; MPA, microscopic polyangiitis; WG, Wegener’s granulomatosis;
RLV, renal limited vasculitis; SLE, systemic lupus erythematosus; HSN, Henoch-Scho¨nlein nephritis; Aza, azathioprine; Cyclo, cyclophosphamide;
Pred, prednisolone; MP, methylprednisolone; NA, not available.
a At time of biopsy
b Biopsies used for immunohistochemical analyses
c An active lesion is classified as capillary loop thrombosis, cellular or fibrocellular crescents
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65°C for five minutes and then brought to a volume of 1 ml
by hybridization solution [66% formamide, 7.5% dextran
sulphate, 1.33 mM EDTA (pH 8.0), 13.33 mM Tris (pH 8.0)
and 0.4 M NaCl] and kept at 65°C for immediate use. cDNA
plasmid templates were a gift from Professor D. Adams and
Dr. S. Afford (Liver Laboratories, Queen Elizabeth Med-
ical Centre, Birmingham, UK).
In situ hybridization
Sections were brought to room temperature, vacuum
desiccated for 30 minutes and digested in 0.001% protein-
ase K (in 100 mM Tris pH 8.0, 50 mM EDTA pH 8.0) for 30
minutes at 37°C, refixed in 4% PFH in PBS for 20 minutes,
rinsed briefly (32) in water, equilibrated in 0.1 M trietha-
nolamine (TEA) at pH 8.0 for 2.5 minutes and acetylated in
0.2% acetic anhydride in TEA for 10 minutes at room
temperature. Sections were washed briefly in 23 standard
saline citrate (SSC), dehydrated in ascending ethanol con-
centrations (50 to 100%) and vacuum desiccated for 60
minutes. They were then immediately hybridized with 1 3
106 cpm probe in a volume of 50 ml for 16 hours at 52.5°C.
Post-hybridization, sections were sequentially washed in
4 3 SSC (4 changes), digested with 20 mg/ml RNase A (in
0.5 M NaCl, 0.01 M Tris pH 8, 0.001 M EDTA pH 8.0) for 30
minutes at 37°C, desalinated at room temperature (in
descending SSC concentrations) and washed in 0.1 3 SSC
for 60 minutes at 65°C. Sections were then briefly rinsed in
0.1 3 SSC at room temperature and dehydrated in ethanol
with 0.1 3 SSC. Post-RNase A treatment, DTT was added
at a concentration of 1 mM to all solutions. Dehydrated
sections were further vacuum desiccated, dipped in photo-
graphic emulsion (Ilford’s K5, Ilford, UK) and stored
desiccated at 4°C for three weeks, then developed, fixed
and counterstained with hematoxylin and eosin. Controls
included the sense probe and RNase A pre-treated sec-
tions. Positive chemography was excluded by running par-
allel dipped non-hybridized slides through the reaction
sequence. Sections were analyzed for silver grain expres-
sion indicative of positive hybridization by dark field illu-
mination and light microscopy in all glomeruli and in 10
randomly selected high power 625 mm2 area tubulointersti-
tial fields, using a graticule counting system (Graticules
Ltd, Tonbridge, UK), where 6.25 mm2 areas within a field
was a single point for counting purposes. A positive field
was scored as 2.5 3 grain counts over adjacent background
fields, strong positivity as 63 background.
Immunohistochemistry
On ten biopsies immunohistochemical analysis was per-
formed (Table 1). All incubations were carried out at room
temperature in a humidified box. Endogenous peroxidase
was blocked with a 10 minutes incubation of 0.1% azide/
0.3% H2O2. Three stage indirect immunohistochemistry
was performed with primary mouse anti-human monoclo-
nal antibodies [CD68 (EB-1), CD3], rabbit anti-mouse
secondary antibodies and a streptavidinABC/HRP conju-
gate. Binding of the tertiary complex was visualized by the
addition of DAB (3,39-diaminobenzidine tetrahydrochlo-
ride). Tissue was counterstained with hematoxylin,
mounted in DPX and coverslipped. To allow for analysis
with ISH data each section was counted for numbers of
macrophages and T-cells within glomeruli and ten 625 mm2
fields within the tubulointerstitium. All antibody reagents
were from DAKO (Copenhagen, Denmark).
Combined ISH/immunohistochemistry
To further identify the contribution of macrophages to
MCP-1 production, ISH for MCP-1 was combined with
immunohistochemistry. Paraformaldehyde fixed tissue sec-
tions were first digested by 0.1% trypsin in 0.01% CaCl2/pH
7.4 for 15 minutes and sequentially blocked with 10 minutes
incubations of 0.1% azide/0.3% H2O2, 0.1% avidin and
0.01% biotin and then immunostained using three stage
indirect immunohistochemistry with an anti-macrophage
monoclonal antibody (PG-M1) directed against a fixative
resistant CD68 epitope [29], a biotin labeled rabbit anti-
mouse secondary antibody and a streptavidin biotin/HRP
complex. All immunostaining steps were performed with
the addition of 5 mg/ml sodium heparin as a RNase
inhibitor. Following DAB treatment ISH was performed as
described, with the exclusion of the prehybridization steps
of proteinase K digestion and PFH refixation.
Data analysis
Data are presented as mean and SEM. Pearson’s test was
used to correlate chemokine expression with infiltrating
leukocyte numbers.




















63 2.53 63 2.53
MCP-1 (20) 159 30.9 17.6 2 3 104 0.88 1.55
MIP-1a (11) 113 19.4 22.1 1.1 3 104 0.47 0.84
MIP-1b (10) 69 29 23.5 1 3 104 0.88 0.84
RANTES (12) 95 10.5 11.6 1.2 3 104 0.28 0.59
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RESULTS
Broad semiquantitative analysis of chemokine site and
intensity of expression
In situ hybridization using riboprobes is a sensitive
method for the study of specific mRNA within tissue
sections, allowing spatial analysis of expression. We have
used a grain counting system to control for interbiopsy
variability and to provide additional semiquantitative data.
The results are summarized in Table 2 and are expressed as
percentages of glomeruli or percentages of randomly se-
lected 6.25 mm2 area tubulointerstitial fields that contained
Fig. 1. pANCA-positive glomerulonephritis. Heavy intraglomerular ex-
pression of MCP-1 mRNA in a glomerulus with a focal segmental
necrotizing lesion and capillary loop thrombosis (3320).
Fig. 2. (A) Henoch Scho¨nlein nephritis. MIP-1a expression at crescentic
and parietal epithelial sites (3200). (B) Dark field of panel A.
Fig. 3. MIP-1b at crescentic and periglomerular sites around a sclerosed
glomerulus. cANCA 1ve glomerulonephritis (3200).
Fig. 4. (A) Interstitial and proximal tubular expression of MCP-1,
pANCA 1ve glomerulonephritis (3200). (B). Dark field of panel A.
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hybridization signals that were 6 3 or 2.5 3 greater than
the adjacent background. This system only provided local-
ization data on the compartment of expression and a broad
indication of quantity and intensity of expression. There-
fore it was necessary to provide an additional detailed
descriptive analysis of expression (see below).
Table 2 demonstrates that MCP-1, MIP-1a and MIP-1b
were expressed within a substantial proportion of glomer-
uli. The relative intensity of expression of these chemokines
was broadly equivalent at glomerular sites. A smaller
Fig. 5. (A) MIP-1b at interstitial site and proximal tubular epithelial
sites, associated with leukocyte infiltrates (3525). cANCA 1ve glomer-
ulonephritis. (B) Serial section to panel A. MIP-1a expression at the same
site.
Fig. 6. RANTES expression by a proximal tubular epithelial cell (3320)
cANCA 1ve glomerulonephritis.
Fig. 7. MIP-1b associated with a perivascular infiltrate (3160).
Fig. 8. (A) RANTES expression in a patient with pANCA-1ve glomeru-
lonephritis. mRNA expression within the mesangium and at the site of a
glomerular capillary loop (3320). (B) Serial section to panel A. CD 68
positive cells within the glomerular tuft (3525).
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proportion of glomeruli expressed RANTES. Within af-
fected glomeruli chemokine expression was focal at sites of
inflammation and infiltrates. A proportion of glomeruli
were completely negative for all chemokine expression.
Table 2 also shows that at tubulointerstitial sites heaviest
expression was of MCP-1, with a higher intensity of expres-
sion of MIP-1b than MIP-1a. There was substantially less
RANTES expression at tubulointerstitial sites. As a pro-
portion of total tubulointerstitial volume chemokine ex-
pression was very small (less than 1%), however, this
expression was focal and invariably localized to sites of
inflammatory cell infiltrates. In the five normal and three
minimal change biopsies there were 141 and 25 glomeruli
available for analysis, respectively. In these tissues there
was no glomerular expression, and sparse tubular and
interstitial expression of chemokine identified. Only back-
ground levels of grains were detected at tissue edges, in
vascular and tubular lumens, and on sense hybridized
sections. There was minimal positive chemography when
the probe was omitted from the reaction sequence.
There was no difference in patterns of expression be-
tween Wegener’s granulomatosis and microscopic polyan-
giitis. The limited biopsy numbers available and variable
numbers of biopsies in treated and untreated subsets made
an assessment of differences in intensity of expression of an
individual chemokine between different subsets impossible.
Only one biopsy from a patient with renal limited vasculitis
was available for analysis, not allowing for an assessment of
difference of expression in this disease state. The heaviest
expression of chemokines was present in untreated and
anti-GBM disease. Here 42%, 29% 45% and 21% of
glomeruli were positive for MCP-1, MIP-1a, MIP-1b and
RANTES, respectively, at 6 3 the background.
Descriptive analysis of the sites of chemokine expression
Resident cell expression. Chemokines were expressed by
resident glomerular cells, usually local to areas of infiltrat-
ing leukocytes. Where glomeruli were abnormal there was
chemokine expression at mesangial (Fig. 1), and parietal
epithelial sites (Fig. 2). There was heavy presence of
MCP-1 at glomerular capillary loops, and occasional ex-
pression of MIP-1a and MIP-1b (Figs. 1 and 3). When
expressed at this site there were often focal segmental
lesions and glomerular leukocyte infiltrate. This was con-
firmed in colocalization studies and, for MCP-1, in com-
bined ISH/immunohistochemistry studies (see below).
There was relatively sparse expression of RANTES. Where
present, this chemokine was expressed at glomerular cap-
illary loops and colocalized to infiltrating cells in serial
sections. Within the tubulointerstitial compartment there
was expression of all chemokines at proximal tubular
epithelial and interstitial sites (Figs. 4 and 5). Where
expressed by tubular cells, not all cells of a given tubule
expressed chemokine (Fig. 6). In addition MCP-1, MIP-1a
and MIP-1b were identifiable at interstitial vascular sites
associated with perivascular infiltrates (Fig. 7).
Infiltrating cells. Many leukocyte infiltrates were chemo-
kine mRNA associated. Notably, heavy production was
seen in cellular crescents, periglomerular and tubulointer-
stitial infiltrates (Figs. 2 to 5). The heaviest chemokine
expression by leukocytes within the glomerular tuft was of
MCP-1. There was also substantial expression of MIP-1a
and MIP-1b at these sites. There was heavy expression of
MIP-1a and MIP-1b in a crescentic distribution. There was
sparse expression of RANTES, which was localized by
serial sections to infiltrating cells (Fig. 8). Within the
tubulointerstitium there was expression of all chemokines
by infiltrating cells. Not all infiltrates, or cells within
infiltrates, were chemokine expressing. Further informa-
tion on expression by, and colocalization to leukocyte
infiltrates was obtained by immunohistochemical colocal-
ization and combined immunohistochemistry/ISH studies
(for MCP-1).
Macrophage and T cell infiltrates
Ten biopsies were available for immunohistochemical
analysis of CD68 and CD3 1ve cells (Table 1). In general
there were heavy intraglomerular and tubulointerstitial
CD68 and CD3 1ve infiltrates. These intraglomerular
infiltrates were associated with focal segmental lesions and
extracapillary proliferation. Extraglomerular infiltrates
were present at interstitial, tubular and peri-glomerular
sites.
Within the 10 biopsies, 55 glomeruli were available for
analysis with respect to presence of CD68 1ve cells. No
biopsy studied had glomeruli devoid of macrophages. The
mean number of cells/glomerulus (6 SE) was 16.8 (6 7.9).
Seventy-two glomeruli were analyzed with respect to pres-
ence of CD3 1ve cells. The differences in numbers of
glomeruli studied for CD68 or CD3 1ve cells arose due to
variable glomerular numbers in different sections. No
biopsy had glomeruli devoid of T cells. The mean number
of CD3 1ve cells was 11.1 (6 2.6). In some glomeruli there
were heavy CD68 and CD3 1ve infiltrates and a population
of glomeruli had no infiltrating cells. At tubulointerstitial
sites there were focal cellular infiltrates of CD68 1ve
(21.56 6 10.68 cells/625 mm2) and CD3 1ve cells (14.4 6
Table 3. Correlations between mononuclear cell infiltration and
chemokine mRNA expression
MCP-1 MIP-1a MIP-1b RANTES
Glomerular
CD68 0.67a 0.65 0.83a 0.68
CD3 0.48 0.66 0.72 0.74a
Tubulointerstitial
CD68 0.35 0.47 0.86a 0.62
CD3 0.59 0.74 0.62 0.60
Abbreviations are: MCP, monocyte chemoattractant protein; MIP,
macrophage inflammatory protein.
a P , 0.05
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3.5 cells/625 mm2) at tubulointerstitial sites. The focality of
mononuclear cell infiltrates at both glomerular and tubu-
lointerstitial sites was similar to that of chemokine expres-
sion. Limited serial section studies demonstrated the colo-
calization of both macrophages and T cells to areas of
chemokine expression (Fig. 8).
For all four chemokines studied there was a positive
correlation between expression of individual chemokines
and intrarenal macrophage and T cell infiltration at glo-
merular (Table 3) and tubulointerstitial (Table 3) sites. The
strong correlation of RANTES expression with CD3 1ve
cells at glomerular sites is an interesting finding, especially
as levels of RANTES mRNA are lower than for other
chemokines in this study. In vitro analyses in transendothe-
lial assays indicate potent T cell directed chemotaxis for
RANTES [30]; a murine model of crescentic glomerulone-
phritis demonstrated that RANTES is a chemokine of
equal, if not greater importance than MCP-1 in directing T
cell infiltration in acute glomerular inflammation [31].
As some infiltrates and infiltrating cells were chemokine
negative, macrophage attributable MCP-1 production was
directly quantified by combined ISH/immunohistochemis-
try studies.
Combined ISH/immunohistochemistry
Single section colocalization studies identified the ex-
pression of MCP-1 mRNA with infiltrating monocytes
(Figs. 9 and 10). A total of 56.9% (6 11.23) of glomerular
and 53.2% (6 21.5) of tubulointerstitial infiltrating macro-
phages were MCP-1 mRNA expressing. 45.1% (6 9.3) of
glomerular and 53.5% (6 3.3) tubulointerstitial MCP-1
mRNA was produced by non-CD68 1ve cells. For MCP-1
these studies confirmed that at a given time point only a
proportion of infiltrating macrophages are chemokine pos-
itive and that non-macrophages are expressing MCP-1
within the kidney in inflammatory disease.
Serial sections for chemokines
Due to the focality of chemokine expression and the use
of sections for mononuclear cell colocalization, control
studies and section loss during processing only a limited
numbers of sections were available for analysis of colocal-
ization for chemokine expression (Figs. 5 and 11). These
sections demonstrated that mRNA for individual chemo-
kines colocalized to areas of expression of mRNA for other
members of the C-C chemokine family at sites of inflam-
mation.
DISCUSSION
This is the first study to examine multiple C-C chemokine
expression in a range of human inflammatory glomerulo-
nephritis. We demonstrate the concurrent expression of
mRNA for the C-C chemokines MCP-1, MIP-1a, MIP-1b
and RANTES. The important finding is their differential
expression local to, and by, inflammatory cell infiltrates at
both glomerular and tubulointerstitial sites. Serial section
studies with immunohistochemistry colocalize much of this
expression to infiltrating macrophages. In combined immu-
nohistochemistry/ISH studies a substantial proportion of
MCP-1 mRNA expressing cells are macrophages. The
overall patterns of expression differed between individual
chemokines, with heaviest glomerular tuft expression of
MCP-1, and expression of MIP-1a and MIP-1 b in a
crescentic distribution, with further expression of both
chemokines at glomerular capillary loops. Expression of
RANTES was sparse in both glomerular and tubulointer-
stitial compartments. Nevertheless, the strong correlation
of RANTES, when present, with infiltrating CD3 1ve cells
within the glomerulus suggests that this chemokine may be
of particular importance for T cell recruitment to this site.
The sensitivity of leukocytes to chemokines has been
elucidated by in vitro assays. In vivo this process is influ-
enced by other factors that may affect the relative sensitiv-
ity of individual leukocyte subsets. Further, chemokine
mRNA has a short half life, and these molecules may be
only expressed at given time points in the evolution of
disease. The study of half-life of individual chemokine
mRNA in human disease is difficult to perform and the
kinetics of expression impossible to assess without the
benefit of sequential biopsies.
The production of MCP-1 by renal cells has been previ-
ously analyzed, with both cytokines [17, 18] and other
proinflammatory mediators triggering expression. There is
little information, however, on other members of the C-C
family, although data from cells cultured from other organ
systems suggest a similar potential for upregulation on
stimulation [7]. In leukocytes expression has been better
characterized. Stimulated macrophages, T cells and other
leukocytes produce differential amounts of the chemokines
analyzed in this study [7, 32]. The proinflammatory cyto-
kines that trigger production of chemokines from mononu-
clear and non-leukocytic cells in vitro are present in renal
inflammation in vivo. In ANCA-associated glomerulone-
phritis Noronha and colleagues used immunohistochemis-
try and ISH to demonstrate the proinflammatory cytokines
TNF-a and IL-1b at glomerular and tubulointerstitial sites
local to areas of damage [5]. These observations have been
supported by other studies [33, 34]. Collectively they indi-
cate the presence in vivo of a cytokine network with the
potential to stimulate chemokine production by resident
and infiltrating cells.
Analyses of C-C chemokine expression in situ in human
glomerulonephritis is limited to MCP-1. Recently, Gesu-
aldo and colleagues demonstrated the expression of MCP-1
mRNA and protein in cryoglobulinaemic membranoprolif-
erative glomerulonephritis, colocalized to macrophages
and other infiltrating and resident cells [23]. These data
extended earlier immunohistochemical studies. Rovin et al
demonstrated the intraglomerular expression of MCP-1 in
Wegener’s granulomatosis, systemic lupus erythematosus
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and idiopathic crescentic glomerulonephritis, although the
cell of source for MCP-1 was unclear [19]. In renal biopsies
from a heterogeneous group of patients with glomerulone-
phritis, Prodjosudjadi et al analyzed MCP-1 expression at
glomerular and interstitial sites, but found no correlation
between glomerular MCP-1 expression and intraglomeru-
lar macrophage infiltration [20]. In addition, this analysis
indicated diffuse association of MCP-1 with tubular cells.
This pattern of expression is different to that which we
demonstrate at mRNA level, where substantial expression
of MCP-1 and other C-C chemokines was by single tubular
cells. There is debate, however, on the retention of chemo-
kines in the glycocalyx. These proteins may traffic away
from their cell of production and be retained at proximal
tubular and other sites by cell associated and extracellular
matrix proteoglycans. This requires further study. The
heaviest expression of MCP-1 at glomerular capillary loops
does suggest a central role for this chemokine in directing
the transmigration of leukocytes at glomerular sites. In an
animal model of rapidly progressive glomerulonephritis
there is now evidence that MCP-1 may also be involved in
the progression of interstitial fibrosis in renal inflammation
[31].
Studies in animal models provide further insights into the
function of the chemokine network in renal inflammation.
Specific anti-chemokine therapy abrogates glomerular
Fig. 9. Combined immunocytochemistry/ISH. MCP-1 expression colocal-
ized to interstitial macrophages in cANCA 1ve glomerulonephritis
(3525).
Fig. 10. Combined immunocytochemistry/ISH. Heavy MCP-1 expression
at glomerular sites in anti-GBM disease. A number of MCP-1 mRNA
producing cells are macrophages (3320).
Fig. 11. (A) Intraglomerular MCP-1 mRNA expression. pANCA glomer-
ulonephritis (3525). (B) Serial section to panel A. Colocalization of
RANTES mRNA expression to same glomerulus. (C) Dark field of panel
B.
Cockwell et al: C-C chemokine mRNA and glomerulonephritis834
macrophage infiltrates with an associated improvement in
renal function. Wada and colleagues demonstrated that in
an animal model of crescentic glomerulonephritis, anti-
MCP-1 antibodies reduced macrophage infiltration by up
to 30% at three and six day time points [24]. These
observations were supported by Tang, Qi and Warren [25].
In their study using anti-MCP-1 antibodies they demon-
strated a reduction of infiltration by 38% at 18 hours. In
addition, at this time point in untreated animals, 55% of
MCP-1 mRNA was macrophage associated [25], supporting
the data of Gesualdo and ourselves in colocalizing MCP-1
mRNA expression to macrophages in human glomerulone-
phritis. This indicates that infiltrating macrophages them-
selves provide paracrine signals that facilitate further leu-
kocyte infiltration. The incomplete abrogation of
macrophage infiltration by anti-MCP-1 antibodies and the
data presented here suggest substantial functional redun-
dancy in the chemokine network. This concept is supported
at receptor level, as both T cells and macrophage/mono-
cytes express a number of receptors for C-C chemokines.
Several of these receptors are ligated by more than one
chemokine [35].
The demonstration of chemokine transcripts by both
resident and infiltrating cells indicate a positive feedback
loop for macrophage and T cell recruitment, with the early
production of C-C chemokines by cytokine stimulated
resident cells promoting mononuclear cell infiltration. Pro-
duction of C-C and other chemokines by infiltrating cells
themselves amplifies this process. To date over 20 human
C-C chemokines and eight C-C chemokine leukocyte re-
ceptors have been identified. Recent insights into their role
in the regulation of HIV infection [36], proliferation of
resident cells [37] and provision of co-stimulatory signals to
T-cells [38] suggest additional biological roles for these
molecules in renal inflammation. Further, some members
of non-C-C chemokine subfamilies are potent T-cell and
monocyte chemoattractants [12, 39] and are renal ex-
pressed [12, 40].
The studies described here indicate that several members
of the C-C chemokine family recruit macrophages and T
cells in human immune inflammatory glomerulonephritis.
Although MCP-1 has a prominent role in this process,
redundancy in this system may be a potential limitation to
the success of anti-chemokine therapy and indicates that
further analysis of the role of the chemokine network in
human glomerulonephritis is required.
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APPENDIX
Abbreviations used in this article are: ANCA, anti-
neutrophil cytoplasmic antibody; DAB, 3,39-diaminobenzi-
dine tetrahydrochloride; DEPC, diethyl pyrocarbonate;
DTT, dithiothreitol; ISH, in situ hybridization; MCP-1,
monocyte chemoattractant protein-1; MIP, macrophage
inflammatory protein; PBS, phosphate buffered saline;
TEA, triethanolamine.
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